市场调查报告书
商品编码
1591442
拉丁美洲捐卵 IVF 服务市场规模和预测、区域份额、趋势和成长机会分析报告范围:按类型、最终用户和国家分类Latin America Donor Egg IVF Services Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User, and Country |
拉丁美洲捐卵体外受精服务市场规模预计将从2023年的1.3262亿美元成长到2031年的2.9110亿美元;预计 2023-2031 年复合年增长率为 10.3%。
拉丁美洲已成为国际患者寻求负担得起的高品质体外受精治疗的热门生育治疗目的地。与北美和欧洲相比,拉丁美洲的生育手术成本相对较低,使得服务更容易获得,吸引了寻求这些治疗选择的本地和国际患者。卓越技术、成本效益和富有同情心的护理的融合使拉丁美洲成为生育治疗的理想目的地。墨西哥等国家因其较低的成本和成功的治疗结果而吸引了来自美国和其他国家的患者,从而推动了对捐卵服务的需求。
在美国,生育治疗通常不包含在保险范围内,因此价格昂贵且难以获得,根据自付费用生育患者费用:数据显示,新的 IVF 週期平均费用高达约 20,000 美元来自多中心预期不孕症队列。为了获得护理,前往拉丁美洲的治疗目的地是比典型治疗费用更经济、更方便的替代方案,诊所可以以四分之一的价格提供体外受精週期,并提供更高品质的护理和更好的患者体验。拉丁美洲的 IVF 治疗比美国或欧洲便宜 70%,且护理品质不受影响。
此外,由于治疗成本相对较低,墨西哥已成为医疗旅游的主要目的地。 Infertility Aide 是一家在全球范围内联繫医生与不孕症患者的机构,该机构报告称,墨西哥 IVF 的平均总费用(包括药物、监测以及医生和医院的费用)约为 8,000 美元。在墨西哥的医疗旅游领域,辅助生殖是医疗旅游的第三大原因。该国为各种辅助生殖技术治疗提供了有利的监管环境。拉丁美洲没有法律限製或禁止体外受精治疗、卵子捐赠、性别选择、基因筛检或精子捐赠。
巴西也是医疗旅游的主要中心,并正在扩大药物的供应,包括生育治疗。该国共有 150 个提供不孕症治疗的机构。与美国和西欧相比,这些治疗的相关费用非常实惠。因此,负担能力、优质护理、寻求生育治疗(包括捐卵体外受精)的国际患者的涌入以及生育旅游的不断增长正在推动拉丁美洲捐卵体外受精治疗服务市场的扩张。
基于类型的见解
拉丁美洲捐卵体外受精服务市场依类型分为冷冻捐卵和新鲜捐卵。 2023 年,冷冻捐卵细分市场在拉丁美洲捐卵 IVF 服务市场份额中占据更大份额。
基于最终用户的见解
拉丁美洲捐卵体外受精服务市场依最终用户划分为生育诊所及体外受精中心、医院等。 2023 年,生育诊所和 IVF 中心细分市场占据了拉丁美洲捐卵 IVF 服务市场份额最大的份额。
拉丁美洲捐卵体外受精服务市场受到几个关键因素的推动,例如夫妇不孕率的上升以及辅助生殖技术的接受度不断提高,导致对这些服务的需求增加。此外,拉丁美洲的体外受精治疗费用普遍低于已开发国家,使其成为当地和国际患者的理想选择。生育旅游的兴起进一步为扩大捐卵体外受精服务创造了良好的环境,随着来自生育法律限制性国家的个人寻求负担得起且易于获得的生育解决方案,促进了市场成长。 2023 年,巴西占最大市场份额。例如,根据Macrotrends发布的《1950-2024年巴西出生率》,全国2024年的出生率为每1000人12.580人,比2023年的每1000人12.806人下降1.76%。随着越来越多的夫妇面临受孕困难,对捐卵体外受精服务的需求激增。根据2021 年9 月发表的一篇题为《辅助生殖技术和生育力保存的限制》的文章,2012 年至2019 年间,该国进行的试管受精週期数量有所增加,巴西註册诊所数量增加了63%,冷冻胚胎的数量增加了三倍。全国註册的 IVF 诊所数量从 120 家增加到 183 家(资料来源:ANVISA,2020 年)。此外,巴西的受精率显示该国的辅助生殖服务是有效的,达到了国际标准。根据全国胚胎生产系统第十二次报告的资料,该国平均受精成功率为76%,符合国际文献建议的65%至75%的品质标准(资料来源:SisEmbrio,2019)。
此外,巴西拥有辅助生殖技术的支持性法律架构。巴西法规支持匿名卵子捐赠,为患者提供广泛的潜在捐赠者,同时保持捐赠者的机密性。虽然禁止向捐赠者付费,但该国许多诊所提供费用补偿,这鼓励更多的妇女作为捐赠者参与。
此外,2023 年 9 月,生殖科技公司 AIVF 在巴西戈亚尼亚的多学科生育诊所 Perfetto 推出了第一个人工智慧驱动的 IVF 作业系统。 AIVF 开发了一种名为 EMA by AIVF 的专有人工智慧驱动作业系统,旨在帮助 IVF 设施加强患者与临床医生的沟通、优化工作流程并做出更好的临床决策。 AIVF的扩张极大地满足了巴西对辅助生殖技术日益增长的需求。
美国国立卫生研究院 (NIH)、不列颠哥伦比亚医学杂誌、Wiley 和 Fertility and Sterility 是在准备拉丁美洲捐卵 IVF 服务市场报告时参考的主要和次要来源。
The Latin America donor egg IVF services market size is expected to grow from US$ 132.62 million in 2023 and is projected to reach US$ 291.10 million by 2031; it is expected to register a CAGR of 10.3% during 2023-2031.
Latin America has become a popular fertility treatment destination for international patients seeking affordable and high-quality IVF treatments. The relatively lower cost of fertility procedures in Latin America compared to North America and Europe makes the services more accessible, attracting both local and international patients seeking these treatment options. The fusion of technological excellence, cost-effectiveness, and compassionate care makes Latin America an ideal destination for fertility treatments. Countries such as Mexico attract patients from the US and other countries due to lower costs and successful treatment outcomes, which drive demand for donor egg services.
In the US, fertility treatments are most often not covered by insurance, making them price-intensive and inaccessible, with a fresh IVF cycle costing up to ~US$ 20,000 on average, according to the Out-of-Pocket Fertility Patient Expense: Data from a Multicenter Prospective Infertility Cohort. In order to access care, traveling to treatment destinations in Latin America is a more budget-friendly and convenient alternative to typical treatment costs, where clinics can offer IVF cycles at a quarter of the price with greater quality of care and better patient experience. IVF treatments in Latin America can be as much as 70% cheaper than in the US or Europe without compromising the quality of care.
Moreover, Mexico has established itself as a leading destination for medical tourism due to the relatively low treatment costs. Infertility Aide, an agency that links doctors with infertility patients globally, reports that the total average cost of IVF in Mexico, covering medications, monitoring, and fees for doctors and hospitals, is around US$ 8,000. Within Mexico's medical tourism sector, assisted reproduction is the 3rd top reason for medical travel. The country has favorable regulatory environments for the wide range of assisted reproductive technology treatments. There is no law in LATAM that restricts or prohibits IVF treatments, egg donation, gender selection, genetic screening, or sperm donation.
Brazil also has been a major center for medical tourism and is expanding the availability of medication, including fertility treatment. The country has a total of 150 facilities offering treatments for infertility. The costs associated with these treatments are highly affordable compared to those of the US and Western Europe. Therefore, affordability, quality care, influx of international patients seeking fertility treatments (including donor egg IVF), and the rising growth of fertility tourism are fueling the expansion of the donor egg IVF treatment services market in Latin America.
Type-Based Insights
The Latin America donor egg IVF services market, by type, is bifurcated into frozen donor egg and fresh donor egg. The frozen donor egg segment held a larger share in the Latin America donor egg IVF services market share in 2023.
End User-Based Insights
The Latin America donor egg IVF services market, by end user, is segmented into fertility clinics and IVF centers, hospitals, and others. The fertility clinics and IVF centers segment held the largest Latin America donor egg IVF services market share in 2023.
The Latin America donor egg IVF services market is driven by several key factors, such as increasing infertility rates among couples coupled with a growing acceptance of assisted reproductive technologies, which has led to heightened demand for these services. Additionally, the cost of IVF treatments in Latin America is generally lower than in developed countries, making it an ideal option for both local and international patients. The rise of fertility tourism further creates a robust environment for the expansion of donor egg IVF services, enhancing market growth as individuals from nations with restrictive reproductive laws seek affordable and accessible fertility solutions. Brazil held the largest share of the market in 2023. The declining birth rate is influencing the growth of infertility treatment across the country. For instance, according to the Brazil Birth Rate 1950-2024 published by Macrotrends, the nation's birth rate in 2024 is 12.580 births per 1,000 people, a 1.76% decline from 2023, which was 12.806 births per 1,000 people. As more couples face challenges in conceiving, the demand for donor egg IVF services has surged. As per an article titled "Restricted access to assisted reproductive technology and fertility preservation," published in September 2021, the number of IVF cycles conducted in the country improved between 2012 and 2019, the number of registered clinics in Brazil increased by 63%, and the number of frozen embryos increased threefold. The number of IVF clinics registered in the nation rose from 120 to 183 (Source: ANVISA, 2020). Additionally, fertilization rates in Brazil indicate that the country's assisted reproduction services are effective, achieving international standards. The country's average fertilization success rate was 76%, which is within the quality standards recommended in the international literature, ranging from 65% to 75%, as per the data from the 12th report of the National System of Embryo Production (Source: SisEmbrio, 2019).
In addition, Brazil has a supportive legal framework for assisted reproductive technologies. The Brazilian regulations support anonymous egg donation, providing patients with a broad pool of potential donors while maintaining donor confidentiality. While paying donors is prohibited, many clinics in the country provide compensation for expenses, which encourages more women to participate as donors.
Moreover, in September 2023, the first AI-powered IVF operating system was introduced in Brazil at Perfetto, a multidisciplinary fertility clinic in Goiania, by the reproductive technology business AIVF. A proprietary AI-powered operating system called EMA by AIVF was developed to assist IVF facilities in strengthening patient-clinician communications, optimizing workflows, and making better clinical decisions. The expansion of AIVF greatly meets Brazil's rising need for assisted reproductive technologies.
The National Institutes of Health (NIH), British Columbia Medical Journal, Wiley, and Fertility and Sterility are among the primary and secondary sources referred to while preparing the Latin America donor egg IVF services market report.